Valuation check: MNKD's profit margin is -11.08%, below the Healthcare sector average of 13.71%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Mannkind (MNKD) currently reports a profit margin of -11.08% as of June 2026. That compares with 13.05% in the prior-year period — down 184.9% year over year. That is below the Healthcare sector average of 13.71%. Use the charts on this page to explore Mannkind's profit margin history and peer comparisons.
Mannkind's profit margin decreased from 13.05% to -11.08% — a 184.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Mannkind's profit margin of -11.08% is lower than the Healthcare sector average of 13.71%. That is roughly 180.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Mannkind's current -11.08% should be judged against Healthcare norms (sector average: 13.71%) and against MNKD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -11.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.71%. From there, open related valuation or income-statement pages for Mannkind, and consider following MNKD for alerts when major investors trade the stock.